Bio Usawa and Yemaachi Biotech Unite to Transform HealthCare in Africa.
Diasporan biotech innovators co-develop monoclonal antibodies and genomic-driven solutions tailored for African patients. Kigali, Rwanda and Accra, Ghana — In a landmark collaboration, Bio Usawa, a pioneering biotechnology company building Africa’s monoclonal antibody development and manufacturing capacity, and Yemaachi Biotech, a leader in African cancer genomics, have joined forces to accelerate precision medicine and pharmacogenomics […]
Bloomberg New Economy Introduces the 2025 Class of Catalysts: Innovators Shaping a more Resilient, Inclusive Global Future.
Join our nine innovators, visionaries, scientists, and entrepreneurs — from Europe, Africa, Asia and North America — at this November’s Bloomberg New Economy Forum New York — October 20, 2025 — Bloomberg New Economy and Bloomberg Businessweek, today announced the 2025 Bloomberg New Economy Catalysts — a global community of entrepreneurs, scientists, policymakers, and visionaries driving transformative solutions […]
Precision Medicine on a Budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.
Alexandra Lindsey Djomkam Zune , Charles Ochieng’ Olwal, Emmanuel Agbeli , Abdoulaye Baniré Diallo , Emmanuella Amoako, Yaw Bediako , Lily Paemka. Abstract Variations in drug-metabolizing enzymes and transporters are associated with adverse drug reactions (ADRs). ADRs to cancer drugs can differ among populations owing to environmental and genetic differences. Due to limited resources and prohibitive costs associated with drug development, African countries rely on […]